The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome
Background: The COVID-19 pandemic caused by SARS-CoV-2 continues to pose a significant threat worldwide, with severe cases leading to hospitalization and death. This study aims to evaluate the potential use of serum nucleocapsid antigen (NAg) and Krebs von den Lungen-6 glycoprotein (KL-6) as biomark...
Main Authors: | Stefano Sanduzzi Zamparelli, Vincenzo Fucci, Gaetano Rea, Francesco Perna, Marialuisa Bocchino, Alessandro Sanduzzi Zamparelli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/14/6/642 |
Similar Items
-
Significance of serum Krebs von den Lungen-6 in systemic sclerosis
by: Noha Hosni Ibrahim, et al.
Published: (2023-11-01) -
Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients
by: Vito D’Agnano, et al.
Published: (2022-07-01) -
Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis
by: Myeong Geun Choi, et al.
Published: (2022-12-01) -
Serum Krebs von den Lungen (KL-6) level as a marker of exacerbation of interstitial lung diseases
by: Zainab H. Saeed, et al.
Published: (2020-11-01) -
Krebs von den lungen-6 as a clinical marker for hypersensitivity pneumonitis: A meta-analysis and bioinformatics analysis
by: Jie He, et al.
Published: (2022-11-01)